Your browser is no longer supported. Please, upgrade your browser.
Settings
GALE [NASD]
Fura Emeralds Inc.
Index- P/E- EPS (ttm)-0.31 Insider Own0.30% Shs Outstand153.85M Perf Week-4.08%
Market Cap216.93M Forward P/E- EPS next Y-0.29 Insider Trans0.00% Shs Float153.14M Perf Month-21.67%
Income-36.60M PEG- EPS next Q-0.09 Inst Own14.80% Short Float11.39% Perf Quarter-7.84%
Sales9.30M P/S23.33 EPS this Y63.50% Inst Trans2.77% Short Ratio7.10 Perf Half Y-33.80%
Book/sh0.30 P/B4.70 EPS next Y12.10% ROA-44.00% Target Price5.14 Perf Year-36.49%
Cash/sh0.15 P/C9.15 EPS next 5Y- ROE-102.50% 52W Range1.33 - 3.58 Perf YTD-6.62%
Dividend- P/FCF- EPS past 5Y24.20% ROI-114.50% 52W High-60.61% Beta1.36
Dividend %- Quick Ratio1.00 Sales past 5Y- Gross Margin84.90% 52W Low6.02% ATR0.10
Employees57 Current Ratio1.10 Sales Q/Q146.20% Oper. Margin- RSI (14)38.36 Volatility4.33% 6.50%
OptionableYes Debt/Eq0.23 EPS Q/Q86.70% Profit Margin- Rel Volume0.77 Prev Close1.35
ShortableYes LT Debt/Eq0.12 EarningsMay 06 AMC Payout- Avg Volume2.46M Price1.41
Recom2.40 SMA20-12.09% SMA50-15.56% SMA200-32.53% Volume1,885,800 Change4.44%
Mar-09-15Reiterated Needham Buy $7 → $4
Nov-20-14Reiterated MLV & Co Buy $3 → $5
Aug-22-14Reiterated MLV & Co Buy $5 → $3.50
Aug-12-14Reiterated Needham Buy $9 → $7
Feb-03-14Reiterated Noble Financial Buy $4 → $6
Jan-21-14Reiterated Maxim Group Buy $9 → $11
Jan-08-14Reiterated Maxim Group Buy $6 → $9
Nov-26-13Initiated Oppenheimer Outperform $6
Mar-25-13Initiated Needham Buy $3.50
Nov-28-12Initiated Aegis Capital Buy $6
Nov-05-12Initiated Maxim Group Buy $5
Oct-25-12Initiated MLV & Co Buy $6
Jun-04-12Initiated Cantor Fitzgerald Buy $4
Mar-26-15 07:05AM  Galena Biopharma Expands Patient Population in NeuVax(TM) (nelipepimut-S) and trastuzumab Phase 2b Combination Clinical Trial in HER2 1+/2+ Patients GlobeNewswire
Mar-18-15 04:35PM  Galena Biopharma Announces Closing of Public Offering of Common Stock and Warrants GlobeNewswire
08:38AM  How Galena (GALE) Stock Stands Out in a Strong Industry - Tale of the Tape
Mar-16-15 01:19PM  Most active Nasdaq-traded stocks
12:33PM  3 Stocks Near 52-Week Lows to Buy Now - Analyst Blog
06:08AM  GALENA BIOPHARMA, INC. Files SEC form 8-K, Entry into a Material Definitive Agreement, Other Events, Financial Statem
Mar-13-15 03:06PM  3 Biotech Stocks on Traders' Radars: Technical Charts at TheStreet -17.92%
01:04PM  GALENA BIOPHARMA, INC. Financials
09:22AM  Galena Biopharma Announces Pricing of Public Offering of Common Stock and Warrants GlobeNewswire
Mar-12-15 04:01PM  Galena Biopharma Announces Proposed Public Offering of Common Stock and Warrants GlobeNewswire
Mar-09-15 04:23PM  Should You Leave Galena To The Day Traders? at Investopedia -5.85%
08:50AM  Galena Biopharma (GALE) Falls: Stock Goes Down 6% - Tale of the Tape
Mar-05-15 06:03PM  Galena Biopharma reports 4Q loss
04:15PM  GALENA BIOPHARMA, INC. Files SEC form 8-K, Results of Operations and Financial Condition, Financial Statements and Ex
04:10PM  Galena Biopharma Reports Fourth Quarter and Year End 2014 Financial Results GlobeNewswire
Mar-03-15 07:05AM  Galena Biopharma to Present at the 27th Annual ROTH Conference GlobeNewswire
Feb-19-15 07:05AM  Galena Biopharma to Report Fourth Quarter and Year End 2014 Financial Results on Thursday, March 5, 2015 GlobeNewswire +5.68%
Feb-09-15 08:50AM  GALENA BIOPHARMA, INC. Files SEC form 8-K, Other Events, Financial Statements and Exhibits EDGAR Online
07:05AM  Galena Biopharma Enrolls 700th Patient in NeuVax(TM) (nelipepimut-S) Phase 3 PRESENT Clinical Trial GlobeNewswire
Feb-05-15 07:05AM  Galena Biopharma Announces Orexo's Filing of a Patent Infringement Lawsuit Against Actavis Concerning Abstral(R) (fentanyl) Sublingual Tablets in the U.S. GlobeNewswire
Jan-28-15 07:05AM  Galena Biopharma to Present at the 17th Annual BIO CEO & Investor Conference GlobeNewswire
Jan-20-15 07:05AM  Galena Biopharma Hires Joseph Lasaga as Vice President, Business Development and Alliance Management GlobeNewswire
Jan-15-15 07:05AM  Galena Biopharma to Present at the Noble Financial Capital Markets 11th Annual Investor Conference GlobeNewswire -5.91%
Jan-14-15 04:54PM  GALENA BIOPHARMA, INC. Files SEC form 8-K, Other Events EDGAR Online
Jan-08-15 07:05AM  Galena Biopharma Provides 2015 Outlook GlobeNewswire
Dec-15-14 11:49AM  Nominees for Absolute Worst Bio-Technology CEOs of 2014 Are ... at TheStreet
Dec-11-14 08:35AM  Galena Biopharma Presents HER2 Screening Data Including Preliminary Leica Bond Oracle(TM) Results From the Phase 3 NeuVax(TM) (nelipepimut-S) Clinical Trial at the 2014 San Antonio Breast Cancer Symposium (SABCS) GlobeNewswire
Dec-08-14 07:05AM  Galena Biopharma Presents GALE-401 (Anagrelide Controlled Release) Clinical Trial Data at the 56th American Society of Hematology (ASH) Annual Meeting & Exposition GlobeNewswire
Dec-05-14 07:05AM  Galena Biopharma to Present HER2 Screening Data From the Phase 3 NeuVax(TM) (nelipepimut-S) Clinical Trial at the 2014 San Antonio Breast Cancer Symposium (SABCS) GlobeNewswire
Dec-03-14 10:25AM  InMed Pharma's Hiring of Tiberend Highlights Biotech Focus Accesswire
Dec-02-14 07:05AM  Galena Biopharma Receives Notice of Allowance of U.S. Patent Application for GALE-401 (Anagrelide Controlled Release) Composition of Matter GlobeNewswire
Dec-01-14 04:54PM  GALENA BIOPHARMA, INC. Files SEC form 8-K, Other Events EDGAR Online
07:05AM  Galena Biopharma to Present GALE-401 (Anagrelide Controlled Release) Phase 1 Clinical Trial Data at the 56th American Society of Hematology (ASH) Annual Meeting & Exposition GlobeNewswire
Nov-25-14 07:05AM  Galena Biopharma to Present at the Oppenheimer 25th Annual Healthcare Conference GlobeNewswire
Nov-24-14 09:39AM  Galena, Shunned by Wall Street, Forced to Seek Pricey Vulture Financing at TheStreet -8.70%
Nov-20-14 04:21PM  GALENA BIOPHARMA, INC. Files SEC form 8-K, Entry into a Material Definitive Agreement, Financial Statements and Exhib EDGAR Online
04:20PM  Galena Biopharma Announces Purchase Agreement for Up to $55.0 Million With Lincoln Park Capital Fund, LLC GlobeNewswire
10:05AM  UPDATE: MLV & Co Reiterates On Galena Biopharma As External Risks Have Subsided Benzinga
Nov-18-14 07:05AM  Galena Biopharma Completes Enrollment in GALE-401 (Anagrelide Controlled Release) Phase 2 Clinical Trial GlobeNewswire
Nov-13-14 07:05AM  Galena Biopharma to Present at the Stifel 2014 Healthcare Conference GlobeNewswire
Nov-11-14 07:05AM  Galena Biopharma Doses First Patient in Phase 2 Clinical Trial With NeuVax(TM) (nelipepimut-S) in Combination With Herceptin(R) (trastuzumab) to Treat High-Risk HER2 3+ or HER2 Gene-Amplified Breast Cancer Patients GlobeNewswire
Nov-07-14 05:26PM  GALENA BIOPHARMA, INC. Files SEC form 8-K, Change in Directors or Principal Officers EDGAR Online
04:28PM  Another lackluster session for major equities Yahoo Finance Blogs
07:05AM  Galena Biopharma Presents GALE-301 (Folate Binding Protein Immunotherapy) Phase 2a Clinical Trial Data at the Society for Immunotherapy of Cancer (SITC) 29th Annual Meeting GlobeNewswire
Nov-05-14 04:38PM  GALENA BIOPHARMA, INC. Files SEC form 10-Q, Quarterly Report EDGAR Online
Nov-04-14 07:05AM  Galena Biopharma to Present GALE-301 (Folate Binding Protein) Phase 2a Clinical Trial Data at the Society for the Immunotherapy of Cancer (SITC) 29th Annual Meeting on Friday, November 7, 2014 GlobeNewswire
Nov-03-14 05:21PM  Galena Biopharma beats 3Q profit forecasts AP -6.83%
04:33PM  GALENA BIOPHARMA, INC. Files SEC form 8-K, Results of Operations and Financial Condition, Financial Statements and Ex EDGAR Online
04:20PM  Galena Biopharma Reports Third Quarter 2014 Results GlobeNewswire
02:00PM  Heat Biologics Takes a New Approach to Immunotherapy Accesswire
07:07AM  Q3 2014 Galena Biopharma Inc Earnings Release - After Market Close CCBN
Oct-27-14 07:05AM  Galena Biopharma to Report Third Quarter 2014 Financial Results on Monday, November 3, 2014 GlobeNewswire +5.26%
Oct-14-14 07:05AM  Galena Biopharma Receives Notice of Allowance of Improvement Patent for NeuVax(TM) (nelipepimut-S) in Japan GlobeNewswire +5.06%
Oct-09-14 06:51AM  Weakness Seen in Galena Biopharma (GALE) Estimates: Should You Stay Away? Zacks
Oct-08-14 07:05AM  Galena Biopharma Announces Notice of Allowance of U.S. Patent Application for NeuVax(TM) (nelipepimut-S) Combination GlobeNewswire
Sep-26-14 05:18PM  GALENA BIOPHARMA, INC. Files SEC form 8-K, Other Events, Financial Statements and Exhibits EDGAR Online
Sep-25-14 04:15PM  Galena Biopharma Announces Release of Special Committee Report and Hosting of a Conference Call to Provide a Corporate Update GlobeNewswire
Sep-18-14 04:45PM  GALENA BIOPHARMA, INC. Files SEC form 8-K, Change in Directors or Principal Officers EDGAR Online
Sep-09-14 07:05AM  Galena Biopharma Doses First Patient in GALE-401 (Anagrelide Controlled Release) Phase 2 Clinical Trial GlobeNewswire
Sep-03-14 07:05AM  Galena Biopharma to Present at the Rodman & Renshaw 16th Annual Global Investment Conference GlobeNewswire
Aug-27-14 11:36AM  Why Galena Biopharma (GALE) Stock Is Spiking Today at TheStreet +5.98%
07:59AM  UPDATE: MLV & Co Reiterates On Galena Biopharma On Positive Long-Term Outlook Benzinga
Aug-25-14 08:48AM  Galena Fires CEO Ahn, Offers No Parting Gifts at TheStreet
Aug-22-14 04:47PM  GALENA BIOPHARMA, INC. Files SEC form 8-K, Change in Directors or Principal Officers, Other Events, Financial Stateme EDGAR Online
08:48AM  Biotech Stock Mailbag: Threshold, Galena, CytRx at TheStreet
Aug-21-14 07:16AM  Galena CEO Fired Following Stock-Promotions Scandal at TheStreet -5.17%
07:05AM  Galena Biopharma Appoints Mark W. Schwartz, Ph.D., as President and Chief Executive Officer GlobeNewswire
Aug-15-14 07:22AM  Biotech Stock Mailbag: Exact Sciences, Galena, Amgen at TheStreet
Aug-11-14 10:20PM  Intercept Pharma Soars On Positive Liver Drug Data at Investor's Business Daily
04:35PM  GALENA BIOPHARMA, INC. Files SEC form 8-K, Results of Operations and Financial Condition, Financial Statements and Ex EDGAR Online
04:35PM  Galena Biopharma Reports Second Quarter 2014 Results GlobeNewswire
07:07AM  Q2 2014 Galena Biopharma Inc Earnings Release - After Market Close CCBN
Jul-29-14 07:05AM  Galena Biopharma to Report Second Quarter 2014 Financial Results on Monday, August 11, 2014 GlobeNewswire
Jul-28-14 12:34PM  Galectin Pays Stock Promoters to Entice Retail Investors at TheStreet
Jul-22-14 04:52PM  GALENA BIOPHARMA, INC. Files SEC form 8-K, Entry into a Material Definitive Agreement, Financial Statements and Exhib EDGAR Online
04:24PM  Galena Stock: What to Watch for at Motley Fool
09:55AM  Galena 'stands little chance' of improving Zuplenz sales, TheStreet says at theflyonthewall.com
09:41AM  Galena Gives Sales Team Another Useless Product to Promote at TheStreet
07:21AM  Galena enters into licensing agreement with MonoSol Rx theflyonthewall.com
07:15AM  MonoSol Rx Enters Into Exclusive Licensing Agreement With Galena Biopharma for Zuplenz(R) Oral Soluble Film GlobeNewswire
07:05AM  Galena Biopharma Enters Into Definitive Agreement to License U.S. Rights for Zuplenz(R) (ondansetron) Oral Soluble Film GlobeNewswire
Jul-07-14 06:30PM  Biotech Accused in Stock-Pump Scheme at Barrons.com
Jul-02-14 04:41PM  GALENA BIOPHARMA, INC. Files SEC form 8-K, Submission of Matters to a Vote of Security Holders EDGAR Online
09:49AM  Trade-Ideas: Galena Biopharma (GALE) Is Today's "Perilous Reversal" Stock at TheStreet
Jul-01-14 07:05AM  Galena Biopharma Receives Notice of Allowance of Broad U.S. Patent for NeuVax(TM) (nelipepimut-S) GlobeNewswire +6.21%
Jun-20-14 06:04PM  Why Shorts Are Taking Aim at This Marijuana Stock at Motley Fool
Jun-19-14 07:05AM  Galena Biopharma to Present at the 9th Annual JMP Securities Healthcare Conference GlobeNewswire
Jun-18-14 10:01AM  3 Things That Actually Matter for Galena Investors at Motley Fool
09:52AM  Stock To Watch: Galena Biopharma (GALE) In Perilous Reversal at TheStreet
Jun-17-14 02:10PM  Why Galena Biopharma Inc. Shares Spiked Higher at Motley Fool +6.64%
07:05AM  Galena Biopharma Completes Enrollment in GALE-301 Phase 2a Clinical Trial in Ovarian and Endometrial Cancers GlobeNewswire
Jun-16-14 10:22AM  Galena Biopharma (GALE) Marked As A Dead Cat Bounce Stock at TheStreet
08:00AM  Theralase's Cancer Technology Demonstrates Vaccine-Like Properties Accesswire
Jun-13-14 10:11AM  Galena Promoting Experimental Breast Cancer Drug With Faux News Articles Again at TheStreet -6.77%
Jun-11-14 06:11PM  Is It Time to Buy Galena? at Motley Fool
Jun-10-14 05:16PM  Why Achillion Pharmaceuticals, Receptos, and Galena Biopharma Are Today's 3 Best Stocks at Motley Fool +16.79%
Jun-06-14 10:32AM  Biotech Stock Hate Mailbag: The Hostile React-o-Meter Meltdown Edition at TheStreet
Jun-02-14 07:05AM  Galena Biopharma Presents GALE-301 Phase 1 Data at the American Society of Clinical Oncology (ASCO) 50th Annual Meeting GlobeNewswire
May-30-14 07:05AM  Galena Biopharma to Present at the Jefferies 2014 Global Healthcare Conference GlobeNewswire
May-29-14 07:00AM  The Seven Deadly Sins of Biotech Investing at TheStreet
Galena Biopharma, Inc., a biopharmaceutical company, focuses on developing and commercializing oncology therapeutics that address major unmet medical needs across cancer care. Its commercial products include Abstral, a sublingual tablet that is used for the management of breakthrough pain in patients with cancer; and Zuplenz, an oral soluble film for use in the prevention of emetogenic chemotherapy-induced, radiotherapy-induced, and post-operative nausea and vomiting. The company's lead product candidate comprise NeuVax (nelipepimut-S), which is in Phase III clinical trials for use in the prevention of recurrence in early- stage and node-positive breast cancer with low to intermediate human epidermal growth factor receptor (HER2) expression; Phase IIb clinical trials in combination with Herceptin that is used for HER2 1+/2+ node-positive and high-risk node-negative breast cancer treatment; and Phase II clinical trials in combination with Herceptin for use in HER2 gene-amplified breast cancer treatment. It also develops GALE-301 (folate binding protein), which is in Phase IIa clinical trials that is used for the prevention of recurrence in patients with ovarian and endometrial cancers; and GALE-401 (anagrelide controlled release), which has completed Phase I clinical trials that is used for the treatment of patients with myeloproliferative neoplasms to lower elevated platelet levels. Galena Biopharma, Inc. has strategic development and commercialization partnership with Dr. Reddy's Laboratories Ltd. for NeuVax in breast and gastric cancers. The company was formerly known as RXi Pharmaceuticals Corporation and changed its name to Galena Biopharma, Inc. in September 2011. Galena Biopharma, Inc. was founded in 2003 and is based in Portland, Oregon.